History
  • No items yet
midpage
Wellogix, Inc. v. Accenture, L.L.P.
716 F.3d 867
| 5th Cir. | 2013
Read the full case

Background

  • Wellogix alleged Accenture misappropriated its trade secrets after a nine-day trial resulting in a unanimous verdict for Wellogix with compensatory and punitive damages.
  • Wellogix’s software targeted planning, procurement, and payment for complex oilfield services and relied on confidential source code and six-point security measures.
  • Wellogix entered 2005 agreements with SAP to integrate its software with SAP’s accounting, sharing source code with SAP.
  • Wellogix shared source code with Accenture under confidentiality obligations during six marketing agreements and pilot projects with BP and others.
  • During BP’s global Purchase-to-Pay pilot, Accenture and SAP allegedly accessed Wellogix trade secrets uploaded to a confidential online portal and developed competing templates.
  • On appeal, Accenture challenged the verdict and damages; the district court denied motions for judgment as a matter of law and for a new trial, after a remittitur of punitive damages.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Existence of a trade secret Wellogix’s technology met the six Bass factors and remained secret. Secrecy was destroyed by public patent disclosures and portal access. Trade secrets existed; jury could infer secrecy despite some disclosures.
Acquisition of trade secrets through improper means Accenture improperly acquired secrets via confidential agreements, eTrans portal access, and bringing confidential materials into BP’s P2P project. Insufficient direct proof of portal access; expert testimony alone insufficient. Sufficient evidence supported improper acquisition by Accenture.
Use of trade secrets Accenture used Wellogix’s templates and content to develop its own complex services work for BP. Templates were not identical and relied on own efforts; use not proven. Evidence supported use of Wellogix trade secrets in Accenture’s P2P work.
Damages Flexible damages approach allowed recovery of compensatory damages based on Wellogix’s value and lost opportunities. Valuation was speculative and lacked objective data; damages were unreliable. Sufficient evidence supported $26.2 million compensatory damages.
Punitive damages due process Malice supported by evidence of deliberate misappropriation and interference with SAP relationship. Punitive award excessive or unwarranted given the evidence. Punitive award upheld as not grossly excessive; ratio and reprehensibility within due process limits.

Key Cases Cited

  • Lavender v. Kurn, 327 U.S. 645 (Supreme Court (1946)) (reversible error requires complete absence of probative facts)
  • Morissette v. United States, 342 U.S. 246 (Supreme Court (1952)) (judges should defer to jury conclusions)
  • Taco Cabana Int’l, Inc. v. Two Pesos, Inc., 932 F.2d 1113 (5th Cir. 1991) (trade secret existence factors and secrecy considerations)
  • In re Bass, 113 S.W.3d 735 (Tex. 2003) (Bass factors for determining trade secret existence)
  • Reeves v. Sanderson Plumbing Prods., Inc., 530 U.S. 133 (Supreme Court (2000)) (credibility and inference in evaluating evidence for verdicts)
Read the full case

Case Details

Case Name: Wellogix, Inc. v. Accenture, L.L.P.
Court Name: Court of Appeals for the Fifth Circuit
Date Published: May 15, 2013
Citation: 716 F.3d 867
Docket Number: 11-20816
Court Abbreviation: 5th Cir.